A novel p62-ZZ domain blocker in animal models of multiple myeloma-associated bone disease Sep. 16, 2014
Almirall presents novel inhaled compounds with the ability to reduce airway inflammation Sep. 16, 2014
Ultragenyx presents promising interim phase I/II results for rhGUS enzyme replacement therapy Sep. 16, 2014
RSS